Voyager Therapeutics, Inc. (VYGR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:26PM EDT. Market open.
| Previous Close | 8.36 |
| Open | 8.65 |
| Bid | 8.51 x 100 |
| Ask | 8.55 x 200 |
| Day's Range | 8.27 - 8.65 |
| 52 Week Range | 6.06 - 14.34 |
| Volume | |
| Avg. Volume | 662,596 |
| Market Cap | 463.388M |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | 2.87 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
Jazz's (JAZZ) first-quarter earnings and sales miss the mark. The company reaffirms its guidance for full-year 2024.
- Simply Wall St.
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Voyager Therapeutics (NASDAQ:VYGR) has had a rough week with its share price down 14%. However, a closer look at its...
- Barrons.com
Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.
Voyager Therapeutics has surely tried investors’ patience since it came public eight years ago. The biotech firm’s stock has fallen as low as $2.50 from a peak of $30, as its early programs to treat neurological diseases didn’t pan out. Analysts at Guggenheim Securities initiated coverage of the Lexington, Mass.-based biotech with a Buy rating earlier this week.
© 2024 Yahoo. All rights reserved.